Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma.

Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma.

Item
http://www.wikidata.org/entity/Q34542117
Current understanding of lifestyle and environmental factors and risk of non-hodgkin lymphoma: an epidemiological updateTumor necrosis factor-α induced protein 8 polymorphism and risk of non-Hodgkin's lymphoma in a Chinese population: a case-control study.Power of data mining methods to detect genetic associations and interactionsApplication of multi-SNP approaches Bayesian LASSO and AUC-RF to detect main effects of inflammatory-gene variants associated with bladder cancer risk.Polymorphisms in Th1/Th2 cytokine genes, hormone replacement therapy, and risk of non-Hodgkin lymphoma.Non-Hodgkin Lymphoma, Body Mass Index, and Cytokine Polymorphisms: A Pooled Analysis from the InterLymph Consortium.Correlation analysis of gene polymorphisms and β-lactam allergy.Revisiting the Heterogeneous IFN-γ Response of Bacille of Calmette-Guérin (BCG)-Revaccinated Healthy Volunteers in a Randomized Controlled Trial: Effect of the Body Mass Index and of the IFNG+874 A/T PolymorphismGenetics of primary intraocular tumorsGenetic polymorphisms in IL10RA and TNF modify the association between blood transfusion and risk of non-Hodgkin lymphomaNon-hodgkin lymphoma and circulating markers of inflammation and adiposity in a nested case-control study: the multiethnic cohort.Interleukin-9 promotes cell survival and drug resistance in diffuse large B-cell lymphoma.Polymorphism in the interleukin-7 receptor-alpha and outcome after allogeneic hematopoietic cell transplantation with matched unrelated donor.Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma.Body mass index and other anthropometric parameters in patients with diffuse large B-cell lymphoma: physiopathological significance and predictive value in the immunochemotherapy era.Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma.Association of TNF-α, TGF-β1, IL-10, IL-6, and IFN-γ gene polymorphism with acute rejection and infection in lung transplant recipients.
P2860

Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma.

Item
http://www.wikidata.org/entity/Q34542117
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cytokine polymorphisms in Th1/ ...... risk of non-Hodgkin lymphoma.
@ast
Cytokine polymorphisms in Th1/ ...... risk of non-Hodgkin lymphoma.
@en
Cytokine polymorphisms in Th1/ ...... risk of non-Hodgkin lymphoma.
@nl
type
label
Cytokine polymorphisms in Th1/ ...... risk of non-Hodgkin lymphoma.
@ast
Cytokine polymorphisms in Th1/ ...... risk of non-Hodgkin lymphoma.
@en
Cytokine polymorphisms in Th1/ ...... risk of non-Hodgkin lymphoma.
@nl
prefLabel
Cytokine polymorphisms in Th1/ ...... risk of non-Hodgkin lymphoma.
@ast
Cytokine polymorphisms in Th1/ ...... risk of non-Hodgkin lymphoma.
@en
Cytokine polymorphisms in Th1/ ...... risk of non-Hodgkin lymphoma.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Cytokine polymorphisms in Th1/ ...... risk of non-Hodgkin lymphoma.
@en
P2093
P2860
P304
P31
P356
10.1182/BLOOD-2010-07-295097
P407
P433
P478
P50
P577
P5875
P698
P932